Status | Study |
Completed |
Study Name: Ranibizumab in Diabetic Vitrectomy Condition: Diabetic Retinopathy Retinal Neovascularisation Date: 2011-03-01 Interventions: Drug: Ranibizumab Intravitreal |
Terminated |
Study Name: Clinical Research on Retinal Neovascularization of Diabetic Retinopathy Condition: The Mechanism of Retinal Neovascularization of Diabetic Retinop Date: 2010-10-26 Interventions: Genetic: genetic analyzer |
Completed |
Study Name: Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy Condition: Diabetic Retinopathy Retinal Neovascularization Date: 2010-04-09 Interventions: Drug: Ranibizumab Ranibizumab |
Active, not recruiting |
Study Name: Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) Condition: Macular Degeneration Age-Related Maculopathies Age-Related Date: 2009-12-02 Interventions: Biological: AAV2-sFLT01 2 x 10 |
Completed |
Study Name: Intravitreal Avastin in Proliferative Retinopathies Condition: Retinal Neovascularization Date: 2007-11-26 Interventions: Drug: Avastin 2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively |
Completed |
Study Name: Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia Condition: Retina Telangiectasis Date: 2007-03-21 Interventions: Drug: Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml) |
Completed |
Study Name: Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion Condition: Branch Retinal Vein Occlusion Date: 2006-08-30 Interventions: Drug: Triamcinolone |
Completed |
Study Name: Krypton-Argon Regression of Neovascularization Study (KARNS) Condition: Diabetic Retinopathy Retinal Neovascularization Date: 1999-09-23 Interventions: Procedure: Blue-Green Argon Laser Treatment |